Apyx Medical Corporation APYX EPS (Diluted)
Discontinued — last reported Q2 '24
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Apyx Medical Corporation in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Apyx Medical Corporation’s 10-Q, filed August 8, 2024, on SEC EDGAR. View the filing →
Ask your AI about Apyx Medical Corporation's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Apyx Medical Corporation's EPS (diluted)?
- Apyx Medical Corporation (APYX) reported EPS (diluted) of -$0.19 in Q2 2024.
- How has Apyx Medical Corporation's EPS (diluted) changed year-over-year?
- Apyx Medical Corporation's EPS (diluted) decreased by 533.3% year-over-year, from -$0.03 to -$0.19.
- What is the long-term trend for Apyx Medical Corporation's EPS (diluted)?
- Over 2 years (2021 to 2023), Apyx Medical Corporation's EPS (diluted) has grown at a 10.8% compound annual growth rate (CAGR), from -$0.44 to -$0.54.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.